???????????????????? ?????????????????????FDA’s budgetary dependence on user costs might edge field in negotiating favorable plan modifications by PDUFA.32 The chance to far more frequently obtain acceptance via a one trial is useful to business. An individual demo is more probable to produce a Fake good end result resulting from type one mistake